Product NDC: | 63629-3206 |
Proprietary Name: | Pentazocine and naloxone |
Non Proprietary Name: | Pentazocine hydrochloride and naloxone hydrochloride |
Active Ingredient(s): | .5; 50 mg/1; mg/1 & nbsp; Pentazocine hydrochloride and naloxone hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63629-3206 |
Labeler Name: | Bryant Ranch Prepack |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA074736 |
Marketing Category: | ANDA |
Start Marketing Date: | 19970121 |
Package NDC: | 63629-3206-3 |
Package Description: | 30 TABLET in 1 BOTTLE (63629-3206-3) |
NDC Code | 63629-3206-3 |
Proprietary Name | Pentazocine and naloxone |
Package Description | 30 TABLET in 1 BOTTLE (63629-3206-3) |
Product NDC | 63629-3206 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Pentazocine hydrochloride and naloxone hydrochloride |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 19970121 |
Marketing Category Name | ANDA |
Labeler Name | Bryant Ranch Prepack |
Substance Name | NALOXONE HYDROCHLORIDE; PENTAZOCINE HYDROCHLORIDE |
Strength Number | .5; 50 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes | Competitive Opioid Antagonists [MoA],Partial Opioid Agonist/Antagonist [EPC],Partial Opioid Agonists [MoA],Opioid Antagonist [EPC],Opioid Antagonists [MoA] |